Mod5 is a multifunctional protein that modifies a subset of tRNAs in the cytoplasm and is also required for an RNA-mediated form of transcriptional silencing. Previous in vivo studies have shown that the nuclear silencing function of Mod5 does not require that the causative tRNA gene encode a Mod5 substrate, although Mod5 is still required. However, previous data have not directly tested whether Mod5 can directly bind substrate and nonsubstrate RNAs. We herein demonstrate that Mod5 directly binds to both substrate and nonsubstrate RNAs, including a highly structured, non-tRNA sequence (5S-rRNA), consistent with previous in vivo data. Furthermore, we show that some RNAs drastically change the aggregation behavior of Mod5 with implications for tRNA gene-mediated silencing.
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Keywords: amyloid fiber; isopentenyl transferase; Mod5; protein aggregation; RNA binding; tRNA modification tRNA isopentenyl transferases are highly conserved enzymes that transfer an isopentenyl group from dimethylallylpyrophosphate (DMAPP) to the N6 position of A37, adjacent to the anticodon [1-9].The Saccharomyces cerevisiae enzyme, Mod5, resides primarily in the cytoplasm where it modifies mitochondrial and cytoplasmic tRNAs [10] [11] [12] . Mod5 modifies a subset of tRNAs with specific sequence requirements (AAA) surrounding the target nucleotide at A37 [13, 14] . Substrates in yeast and humans [15] include TyrÀ, SerÀ, TrpÀ, and Cys-isoacceptor tRNAs. This modification on a tRNA increases tRNA stability [16] and the fidelity and efficiency of translation-an effect related to the tRNA's affinity for the ribosome [2, 5, 17, 18] .
A small fraction of the enzyme also resides in the nucleus [19, 20] , where it is required for a form of Abbreviations DMAPP, dimethylallylpyrophosphate; EM, electron microscopy; GMSA, gel mobility shift assay; RSC, remodel the structure of chromatin; tgm, tRNA gene-mediated.
transcriptional silencing, termed tRNA gene-mediated (tgm) silencing [11, [21] [22] [23] . tgm silencing was originally observed in budding yeast as antagonizing pol II gene promoters adjacent to tRNA genes [24] . The silencing does not involve steric interference, was shown to occur upstream or downstream of the tRNA gene [24] , and is dependent on histone modifications and chromatin remodeling [25] . This phenomenon also requires the clustering of the tRNA genes to the nucleolus, demonstrating a role for nuclear architecture and localization [23, 26, 27] . Deletion of the MOD5 gene relieves silencing of a pol II promoter adjacent to a tRNA gene on a reporter plasmid [21, 23] . Recently, a form of tgm silencing has been proposed to exist in human cells [28] .
Mod5 involvement in tgm silencing mechanisms was further confirmed by the following observations [22] : (a) Mod5 protein is physically associated with tRNA gene loci, (b) Mod physically associates with pol III transcription complex proteins, (c) Mod5 copurifies with multiple proteins of a remodel the structure of chromatin (RSC) and histones that affect tgm silencing, and (d) Mod5 coimmunoprecipitates with precursor-tRNAs (preÀtRNA) that are thought to be found exclusively in the nucleus. Interestingly, Mod5 was found to coimmunoprecipitate with both substrate and nonsubstrate tRNAs for isopentenylation, but preferentially with corresponding nuclear preÀtRNAs in both types of RNA. This was consistent with the observation that tRNA genes encoding substrate or nonsubstrate pre-tRNAs are both capable of conferring tgm silencing [22] , suggesting that the specificity of Mod5 for enzymatic modification of tRNA in the cytoplasm is distinct from that of its nuclear role in transcriptional silencing. Lastly, truncation of the pre-tRNA transcripts by early termination compromised tgm silencing, suggesting the mechanism required a tRNA-like transcript for efficiency.
Based on these data, we hypothesize that complexes between Mod5 and nascent preÀtRNAs at the site of transcription might recruit chromatin modification and remodeling proteins that affect local chromatin structure to impart silencing of nearby transcription by RNA polymerase II. This mechanism would require that Mod5 binds preÀtRNAs whether or not they are substrates for modification at A37, which has not previously been shown. Testing this was complicated by the prion-like tendency of Mod5 to aggregate in solution and in vivo, in agreement with recent studies showing that Mod5 forms heritable amyloid-like aggregates [29] . It is possible to select for this heritable aggregation in vivo by growth in certain fungicides that require loss of Mod5 modifications of tRNAs (e.g., fluconazole). However, this aggregation of Mod5 affects only cytoplasmic tRNA modification and not the nuclear silencing function [11, 22] .
In this study, we show for the first time that Mod5 directly binds to both substrate and nonÀsubstrate RNAs in vitro, as well as the corresponding primary transcript pre-tRNAs. Further, binding to tRNA-like molecules facilitates aggregation of Mod5. We propose a model for tgm silencing that includes binding of pretRNAs by Mod5.
Materials and methods

Recombinant Mod5 expression and purification
The endogenous Mod5 ORF was amplified by PCR from a genomic DNA preparation of yeast BY4741 cells using primers with Nde1 and Xho1 sequences. PCR products were digested with Nde1 and Xho1 and ligated into the pet15B vector, a bacterial expression plasmid with a 69 histidine CÀterminal tag. The plasmid was transformed into BL21 Escherichia coli by electroporation using a Bio-Rad (BioRad Laboratories, Inc., Hercules, CA, USA) Gene Pulser at 2.5 kV, 25 lF, 200 Ohms (http://springerlab.tch.harva rd.edu/springer/uploads/Equipment/Genepulsermanual.pdf ). Eight liters of E. coli was grown to OD (600 nm) 0.55 in LB + 100 lgÁmL À1 ampicillin (37°C) and then induced with 1.5 mM IPTG (5 h, 17°C). Cells were pelleted at 2620 RCF, 15 min, 4°C, and frozen at À80°C. Pellets were resuspended in 120 mL buffer (50 mM Tris/HCl, 50 mM NaCl, pH 7.5) on ice. Cells were lysed using a Divitech Microfluidizer (model 110Y) using two passes with 200-lm orifice cartridge and then 8 passes with 100-lm cartridge. Lysate was centrifuged at 5470 RCF, 15 min, 4°C, and the supernatant combined with 60-mL packed, pre-equilibrated BioRex 70 (Bio-Rad Laboratories, Inc.) cation exchange resin (50 mM Tris/HCL, 50 mM NaCl, pH 7.5). The lysate was allowed to bind for 1 h (4°C) and spun for 5 min at 152 RCF, and the supernatant was discarded. Resin was washed twice with one volume buffer (200 mM NaCl, 50 mM Tris/HCl, pH 7.5). Protein was eluted with two resuspensions using 500 mM NaCl, 50 mM Tris/HCl, pH 7.5 using one packed resin volume. Elutions were loaded onto a 5 mL packed column of TALON nickel affinity resin at 4°C. The column was washed with 50 mL buffer (300 mM NaCl, 20 mM NaPO 4 , pH 7.0) and eluted with 5.5 mL 450 mM imidazole, 50 mM NaPO 4 , 300 mM NaCl, pH 8.0. Eluent was run on an 80 mL Sephacryl S-100 column (2.7 cm diameter 9 19.1 cm height) using 50 mM Tris/ HCl, 50 mM NaCl, pH 7.5 buffer at a rate of 1 mL flowthrough per minute at 4°C. Seven hundred and fifty microliter fractions were collected, examined by SDS/PAGE, and then the 10 highest concentration fractions were combined, aliquoted, and stored at À80°C.
DNA template synthesis
Template DNA fragments for transcription (Fig. S2) were ordered through Integrated DNA Technologies. Lyophilized DNA pellets were dissolved in 10 mM Tris/HCl containing 1 mM EDTA, to a concentration of 100 lM. Equal volumes of overlapping, complementary strand pairs were combined and hybridized at 37°C overnight. Ten microliters of the 50 lM solutions of hybridized DNA was then added to a solution with a final concentration of 0.4 lM DNTPs, 10 mM Tris/HCl, pH 7.4, 50 mM KCl, 1.5 mM MgCl 2 , and up to 5 units Taq DNA polymerase [30] in a final volume of 50 lL. The solutions were then incubated at 35°C for 5 min, 45°C for 5 min, 55°C for 5 min, 65°C for 30 min, and 37°C for 15 min, ethanol-precipitated, resuspended in 15 lL of water, and stored at À20°C.
In vitro transcription and RNA purification
For each transcription reaction, 200 lL solutions of 50 mM Tris/HCl pH 7.5, 15 mM MgCl 2 , 5 mM DTT, 2 mM spermidine, 2 mM ATP, UTP, GTP, CTP, 2/25 of volume template (see above), and empirically titrated His6Àtagged T7 RNA polymerase [31] were incubated 12 h at 42°C. Solutions were centrifuged at 15 400 RCF for 5 min to remove pyrophosphate precipitate, and the supernatants were ethanol-precipitated, gelÀpurified through a 12% polyacrylamide gel, visualized by shadowing with long-wave UV light, and passively eluted out of gel slices. RNA was ethanol-precipitated, resuspended in 19 TE (10 mM Tris/HCl pH 7.5, 0.1 mM EDTA), and stored at À80°C. Radioactive transcripts were prepared as above, except 0.5 mM ATP containing 10 lCi radioactive aÀATP (PerkinÀElmer, Waltham, MA, USA) was substituted in the above reaction and MgCl 2 was reduced to 12 mM.
End-labeling of 5S-rRNA 'Top' was given a constraint of ≤ 100% bound, while 'Bottom' was constrained to ≥ 0%. 
RNA competition assays
Isopentenylation assay
Electron microscopy
Eighteen micromolar Mod5, AE 7.5 lM pLeu/mLeu/pTyr/ mTyr/5S-rRNA, 75 mM NaCl, 3 mM NaPO 4 , 7.5 mM Tris/ HCl (pH 7.4) was incubated for 24 h at 37°C and sonicated briefly [32] . Samples were prepared using conventional methods for negative stain preparation [33] . Imaging was at room temperature using a Morgagni 268 at 100 kV. Images were acquired at 22 0009 with an Orius 2000 CCD camera with a pixel size of 2.4 A.
Results
Mod5 directly binds to substrate and nonsubstrate RNAs
In our in vitro assays, we worked with three tRNAs that are predicted substrates for Mod5Àmodification: matÀTyrÀtRNA (mature tRNA with 5 0 leader, intron and 3 0 trailer removed), preÀSerÀtRNA (with 5 0 leader and 3 0 trailer), and matÀSerÀtRNA (with leader and trailer sequences removed). We also used nonsubstrate mature tRNAs (matÀLeuÀtRNA), nonsubstrate preÀtRNAs (preÀTyrÀtRNA, preÀLeuÀtRNA, and preÀAlaÀtRNA), and nonsubstrate 5S rRNA (Table S1) . MatÀTyr, preÀSer, and matÀSerÀtRNAs contain the AAA 36-38 sequence requirement for modification, while the intron in the preÀTyrÀtRNA disrupts the AAA and thus is not predicted to be modified by the enzyme at A37. The matÀLeu, preÀLeu, matÀAla, and preÀAlaÀtRNA sequences do not contain the required AAA at the anticodon loop, nor an A at position 37, and are therefore predicted to be nonsubstrates for isopentenylation (Table S1 ).
To confirm these predictions and the activity of the isolated Mod5 enzyme, we performed isopentenyl transferase assays in the presence or absence of DMAPP substrate and each RNA. The modification reaction was followed by the digestion of the products with RNase T1 (which cleaves on the 3 0 side of guanosine residues leaving a 3 0 GMP) and analysis of oligonucleotide fragments on denaturing polyacrylamide gels. The transfer of a dimethylallyl/isopentenyl group from DMAPP to the RNA would result in a DMAPP-dependent shift of the indicated RNase T1Àfragment containing the modified base (Fig. S1 ). As predicted, matÀTyr, matÀSer, and pre-Ser tRNAs are modified at the oligo containing the A37 position (Fig. 1A) , while pre-Ala, preÀTyrÀtRNA, preÀLeuÀtRNA, and LeuÀtRNA are not modified ( Fig. 1B ; summarized in Table S1 ). These data confirm the Mod5 substrate specificity in our recombinant enzyme [1,3,5] and show that the enzyme is capable of recognizing the folded substrates used for in vitro binding assays. We note that we see an additional 7mer oligonucleotide that becomes modified in the substrate mat-Ser and pre-Ser-tRNAs in the presence of Mod5 and DMAPP (Fig. 1A) . A possible explanation for this is that there is high sequence similarity in this 7 nt fragment compared to the 10 nt A37-containing fragment (GAAUCC compared to AAAUCC in the A37-containing fragment). Furthermore, although these two sequences reside in different arms of the tRNA, they are at similar relative positions within their respective arms (Fig. S3) . The lack of a third A in the 7 nt fragment as well as differences in positioning within the tRNA might explain the differences in efficiency of modification between the two, in which only~30% of the 7 nt fragment becomes modified under the conditions used compared to nearly 100% in the A37-containing 10 nt fragment.
Gel mobility shift assay (GMSA) analyses demonstrate that Mod5 binds to both substrate and nonsubstrate tRNAs and preÀtRNAs, as well as 5S RNA, within a similar range of protein concentrations ( Fig. 2A-H) . At low concentrations of Mod5, in some cases, there are discrete shifted RNA bands that likely represent monomer, dimer, or higher complexes of RNAs with Mod5, although there is some smearing of signal in lanes consistent with either semistable complexes or variably structured complexes under these conditions. At higher concentrations of protein, these give way for all RNAs to supershift at the gel interface, suggesting a much larger or insoluble complex ( Fig. 2A-H, discussed below) . We will address the implications of these slow-migrating complexes below, but at a minimum, these data suggest that Mod5 directly binds to RNAs regardless of whether the RNA is a substrate for modification.
To investigate the relative binding strengths of these RNAs with Mod5, we used a competition assay in which Mod5 was bound to a constant concentration of 32 PÀla-beled preÀTyrÀtRNA, in the presence of increasing amounts of unlabeled competitor RNAs. We determined apparent IC 50 values for the nonsubstrate preLeuÀtRNA, preÀAlaÀtRNA, and preÀTyrÀtRNA to be similar (0.4, 1.0, and 0.8 lM, respectively, Fig. 3A, D , and E.). We further determined the competitive strength of two other nonsubstrates including a highly structured nonÀtRNA (5S rRNA, Fig. 3F ) and LeuÀtRNA (Fig. 3C) , and one other substrate RNA, TyrÀtRNA (Fig. 3B) . LeuÀtRNA, TyrÀtRNA, and 5S-rRNA sequences (IC 50 values 3.5, 1.5, and 1.6 lM, respectively) competed with similar strengths to other RNAs tested. In general, these data are consistent with our previously published in vivo data showing that Mod5 coimmunoprecipitates with both substrate and nonsubstrate tRNAs [22] and suggests that the capacity to serve as a substrate for modification does not predict which RNAs Mod5 can bind.
Substrates for A37 modification
tRNA accelerates aggregation of Mod5
As noted above, at the higher Mod5:RNA ratios, the majority of the RNA is bound in a complex with proteins that remains near the well interface of the gel, suggesting that the RNA is bound to a multimerized or aggregated form of Mod5. This suggested that aggregation of Mod5 is not prevented by its interaction with RNA and possibly takes the form of amyloid fibers as observed by others [29] . We thus examined the physical form of these interactions further.
To compare the rates of aggregation, we measured solution light scattering using absorbance at 405 nm as a measure of Mod5 precipitation/aggregation over time (Fig. 4A) . The sample containing Mod5 without RNA demonstrated a modest increase in A 405 , while the addition of substrates matÀTyrÀtRNA, preÀSerÀtRNA, or matÀSer-tRNA led to a threefold to eightfold increase in A 405 by 10 h compared to the Mod5Àonly sample. Similarly, addition of nonsubstrate preÀLeuÀtRNA or preÀTyrÀtRNA led to sixfold to sevenfold increase in A 405 . In contrast, combining Mod5 with 5S-rRNA did not lead to a significant change, notable given the GMSA and competition results (Figs 2 and 3) showing Mod5 binding to 5S rRNA. These results suggest that tRNA-like binding accelerates the aggregation of Mod5, but that the nature of the bound RNA is important.
Mod5 forms both punctate aggregates and extended fibers in the presence or absence of RNA Mod5 was previously shown to form amyloid fibers in vitro and aggregates in vivo under selective pressure [11, 29] . We tested whether RNA affects the ability of Mod5 to form amyloid fibers by examining protein samples +/À RNA using fluorescence and electron microscopy (EM). We also imaged fibers formed in the presence of fluorescently labeled preÀSerÀtRNA to test whether the RNA itself was associated with the protein aggregates. Consistent with our GMSAs (Fig. 2A-G) , we observe Mod5 fibers and punctate aggregates bound to the fluorescent RNA (Fig. 4B) . For both protein- only samples and those incubated with various RNAs, we observed both punctate particulates and fibers using EM (Fig. 4C-H ) confirming previous observations [29] . The size of the punctate particulates as well as the presence of fibers suggested protein multimers. Individual fibers had an approximate diameter of 5-10 nm and were often seen in bundles with diameters as large as 50 nm. The resolution of this analysis precluded detection of quantitative differences in the dimensions of individual fibers, while spectroscopic assays for changes in the rate of fiber versus particle formation were inconclusive ( Fig. S4) : thus, more detailed analysis of differences with or without RNA awaits further investigation.
Discussion
We herein demonstrated that Mod5 directly binds to both substrate and nonÀsubstrate RNAs in vitro. This is in agreement with our hypothesis that Mod5-tRNA interactions play a role in the mechanism of tgm -silencing, where Mod5 binds the nascent preÀtRNA transcripts as a prerequisite for subsequent interactions that modify and remodel local chromatin structure. This is consistent with our previous in vivo data showing that Mod5 copurifies with the precursor and mature forms of both substrate and nonsubstrate tRNAs [22] . The ability of the enzyme to bind with similar affinities to both substrate and nonsubstrate pre-tRNAs suggests that although the presence of an AAA at the A36-A38 position of the active site is predictive of modification activity [14] , it is not a major determinant of RNA-binding behavior of Mod5. The observed differences in binding among tRNAs, pretRNAs, and 5S-rRNA are relatively small, suggesting substantial tolerance for variations in RNA structure, as well as sequence, for binding to Mod5.
Interestingly, upon the addition of RNA to purified Mod5, we observed a marked increase in light scattering with all tRNAs and pre-tRNAs tested, but not 5S-rRNA (Fig. 4A ). These observations suggest that tRNA-like molecules can stimulate Mod5 aggregation whether or not they are substrates for isopentenylation (Fig. 4A) . The reason for the markedly different aggregation behavior of 5S-rRNA, even though it binds to Mod5 and can compete with tRNA binding, is currently unclear, but could reflect a fundamentally different structure in the ribonucleoprotein. This would not be surprising, because the enzyme evolved specifically to fit a tRNA structure into the active site [14] and the overall effect on the structure of the complex could be quite distinct with a differently shaped RNA.
A second observation of interest comes from the effect of RNAs on aggregation by Mod5. It was previously shown that Mod5 is able to form amyloid-like aggregates and that this aggregation can be selected in vivo by selecting against functional tRNA-modifying activity in the cytoplasm with an antifungal agent, fluconazole [29] . However, we previously showed that the nuclear silencing function of Mod5 is not ablated when aggregation is selected by this stressor [11] , suggesting that the nuclear pool of Mod5 that is associated with RNA polymerase III transcription complexes and preÀtRNAs was not subject to the aggregation behavior of the cytoplasmic pool. As aggregation of the purified enzyme is not prevented by RNA binding, and if anything is enhanced by it, we infer that the immunity of the nuclear function to fluconazoleselected aggregation might be due to other interactions of Mod5 in the nucleus. We propose an alternative model in which the RNA-bound form of Mod5 could be the 'active' conformation of the nuclear enzyme, with the enhanced aggregation a necessary part of its nuclear function. Under this model, tgm silencing is facilitated by the multimerization of Mod5 which might extend the Mod5-particle to neighboring gene promoters to either attract chromatin modifiers or block access of the transcription machinery to the DNA.
Suzuki and colleagues originally reported that aggregated Mod5 in the cytoplasm conveys resistance to certain fungicides [29] , which might be consistent with the property having evolved in fungi to provide a reserve population of yeast that are resistant to antifungal attack. Interestingly, the human orthologue, TRIT1, has retained both the cytoplasmic and nuclear functions of Mod5 [22] , and we recently demonstrated that it retains the amyloid fibril formation potential of Mod5 [34] . It is not clear why fibril formation would have been retained in an organism as distant from fungi as humans if cytoplasmic aggregation were the selective pressure, although it is possible that this method of removing Mod5 might regulate cholesterol biosynthesis or protein prenylation by modulating the availability of substrates. We suggest an alternative hypothesis, that the fibril formation is a positive attribute in tgm silencing that has been conserved for that reason. The observation that apparent RNA-mediated silencing has been observed near pol III transcription units in human cells [28] would be consistent with such a conservation of function.
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